Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/1992
07/14/1992CA1305057C Calcium salts
07/09/1992WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a)
07/09/1992WO1992011269A1 Novel methylenebisphosphonic acid derivatives
07/09/1992WO1992011267A1 Novel methylenebisphosphonic acid derivatives
07/08/1992EP0448704A4 Osteogenic devices
07/08/1992EP0202282B1 New use of 1,4-dihydropyridine derivatives
07/08/1992CN1062534A Methylenebisphosphonic acid derivatives
07/08/1992CN1062533A Methylenebisphosphonic acid derivatives
07/08/1992CN1062532A Methylenebisphosphonic acid derivatives
06/1992
06/25/1992WO1992010511A1 Compounds and compositions which inhibit bone resorption
06/25/1992WO1992009586A1 Active oxygen inhibitor
06/21/1992WO1992011268A1 Novel methylenebisphosphonic acid derivatives
06/21/1992CA2098734A1 Novel mrthylenebisphosphonic acid derivatives
06/20/1992WO1992011018A1 Improved humanized immunoglobulins
06/11/1992WO1992009697A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR
06/11/1992WO1992009304A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth)
06/02/1992US5118667 Bone growth factors and inhibitors of bone resorption for promoting bone formation
05/1992
05/29/1992WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR
05/29/1992CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3
05/26/1992US5116828 Pharmaceutical composition for treatment of osteoporosis
05/26/1992US5116573 Labelled vitamin d3 derivative and production process thereof
05/22/1992WO1992009203A1 Tnf inhibitors
05/22/1992CA2096623A1 Tnf inhibitors
05/20/1992WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method
05/20/1992EP0486022A2 Naphthalene derivatives
05/17/1992CA2055630A1 Naphthalene derivatives
05/14/1992WO1992007578A1 Use of protective agents against reactive oxygen species
05/14/1992WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140
05/12/1992US5112867 Triphenylmethane derivatives
05/12/1992US5112866 Sulfonylfluorides as intermediates, also useful in treatment of bone disorders, antisecretory, antiulcer
05/05/1992CA1300017C Composition for preventing osteoporosis
04/1992
04/30/1992WO1992007073A1 Osteogenic peptides
04/15/1992EP0480659A2 Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia
04/01/1992EP0477885A2 Parathyroid hormone derivatives
03/1992
03/25/1992EP0476646A1 Calcium uptake inhibitors
03/25/1992EP0476045A1 Bioerodible polymers for drug delivery in bone.
03/19/1992WO1992005187A1 NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM
03/19/1992DE4029499A1 Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New 17- (beta) -oestradiolderivate, process for their production and pharmaceutical compositions containing them
03/19/1992CA2091268A1 17-.beta.-oestradiol derivatives, processes for their preparation and medicaments containing these compounds
03/18/1992EP0474712A1 Lysolecithin derivatives for treating autoimmune diseases.
03/11/1992EP0474374A1 Method for treatment of bone wasting diseases using a progestin
03/08/1992WO1992004310A1 Triarylethylene carboxylic acids with estrogenic activity
03/08/1992CA2089373A1 Triarylethylene carboxylic acids with estrogenic activity
03/04/1992CN1059143A Pyrazolopyridine compound and process for prepn. thereof
02/1992
02/18/1992US5089492 Pharmaceuticals and dietetics containing acylamino acid derivatives
02/11/1992CA2048810A1 Method for treatment of bone wasting diseases
02/07/1992WO1992002235A1 Calcium and trace mineral supplements
02/06/1992WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140
02/05/1992EP0469837A2 Use of a compound in the manufactur of a medicament for lowering of blood uric acid levels
01/1992
01/28/1992US5084450 Progestomimetic and antiesterogenic steroids for animals
01/22/1992EP0467248A2 Pyrazolopyridine compound and processes for preparation thereof
01/08/1992EP0464946A1 5-Isothiazolamine derivates
01/08/1992EP0464509A1 Biphosphonic acid derivatives, their production and use
01/07/1992US5079261 Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis
01/04/1992CA2045003A1 5-isothiazolamine derivatives
01/02/1992EP0463004A1 Metabolic effects of leukaemia inhibitory factor on bone
12/1991
12/31/1991CA1293727C 9-deazaguanines
12/26/1991WO1991019510A1 Osteoinductive pharmaceutical formulations
12/26/1991CA2045293A1 Bisphosphonic acid derivatives, their production and use
12/18/1991EP0461218A1 Oxypurinol salt composition for oral administration for treating hyperurecemia.
12/17/1991US5073562 Antiinflammatory agents; leukotriene by antagonists
12/12/1991WO1991018622A1 Wound healing
12/12/1991WO1991018594A1 The pharmacological use of certain cystine derivatives
12/11/1991EP0460690A2 Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
12/11/1991EP0460488A1 Sulfur-containing heterocyclic compounds
12/11/1991EP0460205A1 Radiolabeled colloid compositions, their use and process for their preparation
12/10/1991US5072042 Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom
12/10/1991US5071841 Sulfur-containing heterocyclic compounds useful for the treatment of osteoporosis, and their production
12/01/1991CA2043468A1 Sulfur-containing heterocyclic compounds
11/1991
11/28/1991WO1991018098A1 Bone and cartilage inductive proteins
11/28/1991WO1991018089A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome
11/28/1991CA2082941A1 Bone and cartilage inductive proteins
11/27/1991EP0458640A2 Use of ergoline derivatives for the treatment of diseases associated with bone demineralization
11/27/1991CN1014891B Process for preparation of di-tert-butyl phenol compounds
11/26/1991CA2042960A1 Method of inhibiting demineralization of bone
11/21/1991EP0457381A2 Delta 2-cephem sulphones
11/20/1991CN1014787B Phenoxyacetic acid derivative and processes for preparing same
11/17/1991WO1991017989A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
11/17/1991CA2083040A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
11/12/1991US5064830 Lowering of blood uric acid levels
11/11/1991WO1991017160A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
11/11/1991CA2082500A1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
11/06/1991EP0455503A1 Composition for treating osteoporosis and hormonal imbalance
11/05/1991US5063234 Method of inhibiting demineralization of bone
11/05/1991CA2041799A1 Composition for treating osteoporosis and hormonal imbalance
10/1991
10/29/1991US5061476 Radiolabeled colloid compositions and method for preparing same
10/15/1991CA1290691C Methods of treating bone diseases by administration of a cysteine proteinase inhibitor
10/03/1991WO1991014785A1 High level expression of basic fibroblast growth factor having a homogeneous n-terminus
10/03/1991CA2039458A1 Methods for treating interleukin-1 mediated diseases
10/02/1991EP0449764A2 A method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptor antagonist
10/02/1991EP0449079A2 Hydantoin derivative
10/02/1991EP0448704A1 Osteogenic devices
10/01/1991CA1289878C Composition for stimulating chondrocytes and osteoblasts (osseinhydroxyapatite compound), method for its production and pharmaceutical products containing said composition
09/1991
09/25/1991EP0448253A2 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
09/24/1991US5051438 Treating leukotriene by mediated diseases; antiinflammatory agents
09/24/1991US5051424 Piperazine compounds which act as sedatives or antidepressants
09/10/1991US5047554 3-substituted-2-oxindole derivatives
09/10/1991CA1288695C Method for increasing bone mass
09/03/1991CA1288424C Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredient
08/1991
08/28/1991EP0444000A2 Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture